tiprankstipranks
Heidelberg Pharma AG (DE:HPHA)
XETRA:HPHA
Germany Market

Heidelberg Pharma AG (HPHA) Income Statement

Compare
0 Followers

Heidelberg Pharma AG Income Statement

Last quarter (Q3 2024), Heidelberg Pharma AG's total revenue was €1.19M, a decrease of -46.82% from the same quarter last year. In Q3, Heidelberg Pharma AG's net income was €-5.59M. See Heidelberg Pharma AG’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
€ 9.86M€ 18.51M€ 1.75M€ 8.49M€ 7.31M
Gross Profit
€ 6.61M€ 13.83M€ -2.96M€ 2.89M€ 3.57M
Operating Expenses
€ 27.82M€ 32.17M€ 22.83M€ 21.45M€ 13.93M
Depreciation and Amortization
€ 879.00K€ 756.58K€ 802.86K€ 734.00K€ 547.00K
EBITDA
€ -18.71M€ -16.19M€ -24.83M€ -17.55M€ -9.60M
Operating Income
€ -21.21M€ -18.33M€ -25.63M€ -18.56M€ -10.36M
Other Income/Expenses
€ 863.31K€ -604.67K€ -507.64K€ -84.32K€ 0.00
Pretax Income
€ -20.35M€ -17.79M€ -26.14M€ -18.37M€ -10.14M
Net Income
€ -20.35M€ -19.70M€ -26.63M€ -18.37M€ -10.15M
Per Share Metrics
€ ―€ ―€ ―€ ―€ ―
Basic EPS
€ -0.44€ -0.53€ -0.82€ -0.61€ -0.36
Diluted EPS
€ -0.44€ -0.53€ -0.82€ -0.61€ -0.36
Weighted Average Shares Outstanding
46.60M 37.24M 32.50M 29.90M 28.21M
Weighted Average Shares Outstanding (Diluted)
46.60M 37.24M 32.50M 29.90M 28.21M
Currency in EUR

Heidelberg Pharma AG Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis